- Biopharmaceutical industries get access to streamlined development and production processes for peptide- or protein-based biologicals. - Health systems benefit from the availability of enhanced or decentralised production systems for innovative health technologies that involve peptides or proteins, and which improve health and care. - Citizens and patients will benefit from better access, availability and affordability of pharmaceuticals based on biologicals.
The conditions for qualifying. An eligibility check tests your details against each one.
At least 3 independent partners
Does your company qualify?
Give a few facts about your company and project, and see for each condition whether you meet it.
Eligibility checkGrant from URBAN PROSUMERS (EU-funded project) across the EU. Total budget €180,000. Applications until 30 September 2026.
- Complete Indicator Framework: A validated indicator framework of short-term actions, outcomes and long-term impacts, for both the ECS programme and the Chips for Europe Initiative, integr…
This topic is the first phase of a two-phase competitive structure supported by Horizon Europe, implemented via a Coordination and Support Action (CSA) in close collaboration with the Europ…
A check is an indication from the published conditions and the facts you give. Only the competent authority decides whether you are eligible.